Cyclica

Name: Cyclica
Address: 207 Queens Quay West #420, Toronto, ON, M5J1A7, CA
Telephone: +14163049201
Price range: Not Applicable

Cyclica - From Molecule to Medicine

Cyclica is the partner of choice for data-driven drug discovery.

We advance molecules that embrace the complexity of the disease. Cyclica is the partner of choice for data-driven drug discovery. Our computational approach to polypharmacology is unique in the industry. We use a proteome-wide lens to evaluate multiple novel and rare on and off-target interactions simultaneously. We’re also the only company of our kind that integrates science to advance molecules

downstream. A structure-based view keeps our work accountable to biology, chemistry, physics, and genomics. To learn more about Cyclica and how we partner, please visit www.cyclicarx.com

09/13/2022

After a little summer pause, M2M is back!

As part of our AI in drug discovery campaign, we have an exciting roundtable lined up titled: “AI in Drug Discovery: Successes, Opportunities and Pitfalls.”

And, what would a panel be without the brightest and the best industry leaders? Ali Madani, Andreas Bender, Brandon Allgood, Pat Walters, and Naheed Kurji.

Registration opens up today! https://lnkd.in/gAPrhzzU

cc: Valo The Alliance for Artificial Intelligence in Healthcare (AAIH) Relay Therapeutics Cambridge University Press – Academic

09/08/2022

In the "bonus" M2M episode, our director of machine learning, Dr. Ali Madani & our machine learning researcher, Dr. Nasim Abdollahi introduce a machine learning framework, using DeepMind's AlphaFold2 structure-augmented protein representations, an essential component in the early AI Drug Discovery process.

Watch the episode here -> https://lnkd.in/gUC2AqKj

08/30/2022

At Cyclica, we’re constantly pushing the boundaries of discovery to address the complexity of the disease.

In collaboration with The Structural Genomics Consortium (SGC), we explored the low data target, DCAF-1, resulting in the first disclosed co-crystallized structure. DCAF-1 is a key component in proteasomal degradation, with a novel ligand to support targeted therapeutics discovery.

Press release 👉 https://lnkd.in/gi3cPrSU

08/25/2022

As part of our AI in drug discovery campaign, Dr. Ali Madani explains the application of AI in drug discovery in his new blog post.

⦿ Check out the post 👉 shorturl.at/efqX7.

⦿ To learn more about our drug discovery application, visit 👉 shorturl.at/bgwY7.

08/18/2022

The current uncertainties globally undeniably impact public and private markets and investments.

This directly impacts how entrepreneurs and operators manage companies. In this post, our CEO, Naheed Kurji, shares his thoughts & some lessons.

📖 👉 👉 https://bit.ly/3K4KNtc (Link in stories)

08/09/2022

The next podcast (5th) episode of Cyclica's M2M (molecule to medicine) is now available on Spotify.

In this episode, Dr. Mike Palovich (Chief Science Officer at Cyclica) & Naheed Kurji (President, Co-founder & CEO of Cyclica) discuss about the journey of a molecule to medicine.

🎧 https://spoti.fi/3vURoR1

08/05/2022

Fresh off the blog!

Our Chief Platform Officer, Dr Stephen MacKinnon, explores new research possibilities following the release of 200 million AlphaFold2 protein structures.

Read the post ➡️ https://bit.ly/3bsR2dD.

08/03/2022

We're looking forward to working with our newest partner, Samjin Pharm, where we will collectively work on proposed novel targets to develop drug target candidates.

Read the press release here 👉 https://bit.ly/3BzE1cJ

07/28/2022

Cyclica was named one of Business Insider’s Top Biotech Startups set to take off in the next 12 months.

We’re incredibly humbled and proud of our team after just learning that Business Insider Insider has named Cyclica to their top list of biotech start-up companies set to take off in the next 12 months.

The prestigious nomination came from Chris Garabedian, who indicates that: “Cyclica could end up being best-in-class in this space, even though others have gotten a lot more attention and attracted a lot more capital.”

Thanks, Chris and to all who have supported Cyclica throughout our journey as we continue to embrace the complexity of the disease.

07/11/2022

Breaking news

We (Cyclica) are hiring, and we are looking to fill 4 positions:

Drug discovery scientist,
computational scientist,
software developer &
computational scientist.

Why join Cyclica?
- awesome team
- fast paced environment
- great culture
- awesome perks, including a two-week company-wide shutdown (summer & winter), unlimited wellness days, four weeks of paid vacation & much more.

Apply here - https://lnkd.in/gUU4jkZ5

07/08/2022

The 3rd episode of our M2M podcast is now available on Spotify!

In this episode, women in STEM trailblazers, Dr. Marti Head & Dr. Melissa Landon discuss small molecules in drug discovery - from the perspective of two brilliant computational scientist.

🎧 here - https://lnkd.in/gzee-yUt

07/07/2022

Check out our newest blog post, where Naheed Kurji shares his take on 5 of Walter Isaacson's books:

📖The Innovators
📖Steve Jobs
📖Leonardo Da Vinci
📖Code Breakers (Jennifer Doudna)
📖Einstein

Read the blog 👉 https://lnkd.in/g3APpbdx

Address

207 Queens Quay West #420
Toronto, ON
M5J1A7

Telephone

+14163049201

Website

http://www.cyclicarx.com/

Alerts

Be the first to know and let us send you an email when Cyclica posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Cyclica:

Want your business to be the top-listed Engineering Company in Toronto?